+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer Diagnostics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, and Product Type

  • PDF Icon

    Report

  • 98 Pages
  • January 2024
  • Region: Global
  • Prof Research
  • ID: 5727890

Quick Summary:

As the world grapples and strategizes to reduce the global cancer burden, understanding the dynamics of the Cancer Diagnostics Market plays a pivotal role. Stay abreast with the latest trends, innovations, and the competitive environment in the cancer diagnostics marketplace with our comprehensive report. This document will be an insightful resource for senior executives, providing detailed insights about key regional markets, notable players, and emerging technologies.

Our market research report analyses the market's primary aspect, including market division, market share, profit margin, major regions, critical players, and the industry's significant growth factors. In addition, the study comprises in-depth SWOT analyses of leading companies ranging from Abbott Laboratories Inc., GE Healthcare to Roche Diagnostics. The broad spectrum covered is not confined merely to the business profiles but extends to a sector-wise analysis, focusing on technology types like liquid biopsy microdevices and paper microfluidic devices. With the knowledge gained through this report, businesses can step up their readiness for the rapidly evolving cancer diagnostics market.

This report describes the global market size of Cancer Diagnostics from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029. This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Cancer Diagnostics as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • Liquid biopsy microdevices
  • Microfluidic immunohistochemistry
  • Paper microfluidic devices

Companies Covered:

  • Abbott Laboratories Inc.
  • Cepheid Inc.
  • Philips
  • GE Healthcare
  • Siemens
  • Gen-Probe Incorporated
  • MDxHealth SA
  • EpiGenomics AG
  • Roche Diagnostics
  • Exact Sciences Corporation
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Cancer Diagnostics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Cancer Diagnostics Market in North America (2019-2029)
8.1 Cancer Diagnostics Market Size
8.2 Cancer Diagnostics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Cancer Diagnostics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Cancer Diagnostics Market in South America (2019-2029)
9.1 Cancer Diagnostics Market Size
9.2 Cancer Diagnostics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Cancer Diagnostics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Cancer Diagnostics Market in Asia & Pacific (2019-2029)
10.1 Cancer Diagnostics Market Size
10.2 Cancer Diagnostics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Cancer Diagnostics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Cancer Diagnostics Market in Europe (2019-2029)
11.1 Cancer Diagnostics Market Size
11.2 Cancer Diagnostics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Cancer Diagnostics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Cancer Diagnostics Market in MEA (2019-2029)
12.1 Cancer Diagnostics Market Size
12.2 Cancer Diagnostics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Cancer Diagnostics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Cancer Diagnostics Market (2019-2024)
13.1 Cancer Diagnostics Market Size
13.2 Cancer Diagnostics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Cancer Diagnostics Market Size by Type
Chapter 14 Global Cancer Diagnostics Market Forecast (2024-2029)
14.1 Cancer Diagnostics Market Size Forecast
14.2 Cancer Diagnostics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Cancer Diagnostics Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Abbott Laboratories Inc.
15.1.1 Company Profile
15.1.2 Main Business and Cancer Diagnostics Information
15.1.3 SWOT Analysis of Abbott Laboratories Inc.
215.1.4 Abbott Laboratories Inc. Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.2 Cepheid Inc.
15.2.1 Company Profile
15.2.2 Main Business and Cancer Diagnostics Information
15.2.3 SWOT Analysis of Cepheid Inc.
215.2.4 Cepheid Inc. Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.3 Philips
15.3.1 Company Profile
15.3.2 Main Business and Cancer Diagnostics Information
15.3.3 SWOT Analysis of Philips
215.3.4 Philips Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.4 GE Healthcare
15.4.1 Company Profile
15.4.2 Main Business and Cancer Diagnostics Information
15.4.3 SWOT Analysis of GE Healthcare
215.4.4 GE Healthcare Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.5 Siemens
15.5.1 Company Profile
15.5.2 Main Business and Cancer Diagnostics Information
15.5.3 SWOT Analysis of Siemens
215.5.4 Siemens Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.6 Gen-Probe Incorporated
15.6.1 Company Profile
15.6.2 Main Business and Cancer Diagnostics Information
15.6.3 SWOT Analysis of Gen-Probe Incorporated
215.6.4 Gen-Probe Incorporated Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.7 MDxHealth SA
15.7.1 Company Profile
15.7.2 Main Business and Cancer Diagnostics Information
15.7.3 SWOT Analysis of MDxHealth SA
215.7.4 MDxHealth SA Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.8 EpiGenomics AG
15.8.1 Company Profile
15.8.2 Main Business and Cancer Diagnostics Information
15.8.3 SWOT Analysis of EpiGenomics AG
215.8.4 EpiGenomics AG Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.9 Roche Diagnostics
15.9.1 Company Profile
15.9.2 Main Business and Cancer Diagnostics Information
15.9.3 SWOT Analysis of Roche Diagnostics
215.9.4 Roche Diagnostics Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
15.10 Exact Sciences Corporation
15.10.1 Company Profile
15.10.2 Main Business and Cancer Diagnostics Information
15.10.3 SWOT Analysis of Exact Sciences Corporation
215.10.4 Exact Sciences Corporation Cancer Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Cancer Diagnostics Report
Table Data Sources of Cancer Diagnostics Report
Table Major Assumptions of Cancer Diagnostics Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Cancer Diagnostics Picture
Table Cancer Diagnostics Classification
Table Cancer Diagnostics Applications
Table Drivers of Cancer Diagnostics Market
Table Restraints of Cancer Diagnostics Market
Table Opportunities of Cancer Diagnostics Market
Table Threats of Cancer Diagnostics Market
Table COVID-19 Impact For Cancer Diagnostics Market
Table Raw Materials Suppliers
Table Different Production Methods of Cancer Diagnostics
Table Cost Structure Analysis of Cancer Diagnostics
Table Key End Users
Table Latest News of Cancer Diagnostics Market
Table Merger and Acquisition
Table Planned/Future Project of Cancer Diagnostics Market
Table Policy of Cancer Diagnostics Market
Table 2019-2029 North America Cancer Diagnostics Market Size
Figure 2019-2029 North America Cancer Diagnostics Market Size and CAGR
Table 2019-2029 North America Cancer Diagnostics Market Size by Application
Table 2019-2024 North America Cancer Diagnostics Key Players Revenue
Table 2019-2024 North America Cancer Diagnostics Key Players Market Share
Table 2019-2029 North America Cancer Diagnostics Market Size by Type
Table 2019-2029 United States Cancer Diagnostics Market Size
Table 2019-2029 Canada Cancer Diagnostics Market Size
Table 2019-2029 Mexico Cancer Diagnostics Market Size
Table 2019-2029 South America Cancer Diagnostics Market Size
Figure 2019-2029 South America Cancer Diagnostics Market Size and CAGR
Table 2019-2029 South America Cancer Diagnostics Market Size by Application
Table 2019-2024 South America Cancer Diagnostics Key Players Revenue
Table 2019-2024 South America Cancer Diagnostics Key Players Market Share
Table 2019-2029 South America Cancer Diagnostics Market Size by Type
Table 2019-2029 Brazil Cancer Diagnostics Market Size
Table 2019-2029 Argentina Cancer Diagnostics Market Size
Table 2019-2029 Chile Cancer Diagnostics Market Size
Table 2019-2029 Peru Cancer Diagnostics Market Size
Table 2019-2029 Asia & Pacific Cancer Diagnostics Market Size
Figure 2019-2029 Asia & Pacific Cancer Diagnostics Market Size and CAGR
Table 2019-2029 Asia & Pacific Cancer Diagnostics Market Size by Application
Table 2019-2024 Asia & Pacific Cancer Diagnostics Key Players Revenue
Table 2019-2024 Asia & Pacific Cancer Diagnostics Key Players Market Share
Table 2019-2029 Asia & Pacific Cancer Diagnostics Market Size by Type
Table 2019-2029 China Cancer Diagnostics Market Size
Table 2019-2029 India Cancer Diagnostics Market Size
Table 2019-2029 Japan Cancer Diagnostics Market Size
Table 2019-2029 South Korea Cancer Diagnostics Market Size
Table 2019-2029 Southeast Asia Cancer Diagnostics Market Size
Table 2019-2029 Australia Cancer Diagnostics Market Size
Table 2019-2029 Europe Cancer Diagnostics Market Size
Figure 2019-2029 Europe Cancer Diagnostics Market Size and CAGR
Table 2019-2029 Europe Cancer Diagnostics Market Size by Application
Table 2019-2024 Europe Cancer Diagnostics Key Players Revenue
Table 2019-2024 Europe Cancer Diagnostics Key Players Market Share
Table 2019-2029 Europe Cancer Diagnostics Market Size by Type
Table 2019-2029 Germany Cancer Diagnostics Market Size
Table 2019-2029 France Cancer Diagnostics Market Size
Table 2019-2029 United Kingdom Cancer Diagnostics Market Size
Table 2019-2029 Italy Cancer Diagnostics Market Size
Table 2019-2029 Spain Cancer Diagnostics Market Size
Table 2019-2029 Belgium Cancer Diagnostics Market Size
Table 2019-2029 Netherlands Cancer Diagnostics Market Size
Table 2019-2029 Austria Cancer Diagnostics Market Size
Table 2019-2029 Poland Cancer Diagnostics Market Size
Table 2019-2029 Russia Cancer Diagnostics Market Size
Table 2019-2029 MEA Cancer Diagnostics Market Size
Figure 2019-2029 MEA Cancer Diagnostics Market Size and CAGR
Table 2019-2029 MEA Cancer Diagnostics Market Size by Application
Table 2019-2024 MEA Cancer Diagnostics Key Players Revenue
Table 2019-2024 MEA Cancer Diagnostics Key Players Market Share
Table 2019-2029 MEA Cancer Diagnostics Market Size by Type
Table 2019-2029 Egypt Cancer Diagnostics Market Size
Table 2019-2029 Israel Cancer Diagnostics Market Size
Table 2019-2029 South Africa Cancer Diagnostics Market Size
Table 2019-2029 Gulf Cooperation Council Countries Cancer Diagnostics Market Size
Table 2019-2029 Turkey Cancer Diagnostics Market Size
Table 2019-2024 Global Cancer Diagnostics Market Size by Region
Table 2019-2024 Global Cancer Diagnostics Market Size Share by Region
Table 2019-2024 Global Cancer Diagnostics Market Size by Application
Table 2019-2024 Global Cancer Diagnostics Market Share by Application
Table 2019-2024 Global Cancer Diagnostics Key Vendors Revenue
Figure 2019-2024 Global Cancer Diagnostics Market Size and Growth Rate
Table 2019-2024 Global Cancer Diagnostics Key Vendors Market Share
Table 2019-2024 Global Cancer Diagnostics Market Size by Type
Table 2019-2024 Global Cancer Diagnostics Market Share by Type
Table 2024-2029 Global Cancer Diagnostics Market Size by Region
Table 2024-2029 Global Cancer Diagnostics Market Size Share by Region
Table 2024-2029 Global Cancer Diagnostics Market Size by Application
Table 2024-2029 Global Cancer Diagnostics Market Share by Application
Table 2024-2029 Global Cancer Diagnostics Key Vendors Revenue
Figure 2024-2029 Global Cancer Diagnostics Market Size and Growth Rate
Table 2024-2029 Global Cancer Diagnostics Key Vendors Market Share
Table 2024-2029 Global Cancer Diagnostics Market Size by Type
Table 2024-2029 Cancer Diagnostics Global Market Share by Type

Companies Mentioned

  • Abbott Laboratories Inc.
  • Cepheid Inc.
  • Philips
  • GE Healthcare
  • Siemens
  • Gen-Probe Incorporated
  • MDxHealth SA
  • EpiGenomics AG
  • Roche Diagnostics
  • Exact Sciences Corporation
  • Sequenom Inc.
  • Cannabics Pharmaceuticals Inc.

Methodology

Loading
LOADING...